AzTrials
AzTrials

Exercise TrainingNCT03438968

Women in Cardiac Rehabilitation: Optimizing the Training Response

A study testing Exercise training in people with Exercise Training and Coronary Artery Disease, run by University of Vermont at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Cardiovascular disease (CVD) is highly prevalent in women resulting in 398,086 deaths annually. Even as women participate in traditional CR programs, data specificity and subsequent research have yet to emerge in a meaningful way so that women-centered CR can be better customized and their outcomes properly assessed. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Exercise Training, Coronary Artery Disease, Women
What is being tested?
Exercise training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteUnited States
Study dates
24 Aug 2017to 30 Apr 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

None listed.

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

Philip A Ades, MD contact

802 847 4514

philip.ades@uvmhealth.org

Sherrie Khadanga, MD contact

802 847 3734

Sherrie.Khadanga@uvmhealth.org

United States1 site, 1 recruiting
  • University of Vermont College of Medicine

    Burlington, Vermont, 05401

    Philip A Ades, MD

    patrick Savage, MS

    Recruiting

Other trials in United States

About this study

Cardiovascular disease (CVD) is highly prevalent in women resulting in 398,086 deaths annually. Even as women participate in traditional CR programs, data specificity and subsequent research have yet to emerge in a meaningful way so that women-centered CR can be better customized and their outcomes properly assessed. Aerobic fitness is a powerful predictor of prognosis in individuals with CVD yet there is evidence that women do not improve their peak VO2 as much as men during CR. We have designed a training program for women based upon past research with a goal of optimizing their training potential in CR. This program combines the utilization of a training technique termed high intensity interval training along with specific strength training exercises of the upper legs. We hypothesize that women, irrespective of age, would be capable of high intensity interval training to improve peak aerobic capacity in the CR setting. Furthermore, since women often have a deficit of thigh strength entering CR, and thigh strength correlates with endurance walking,strength training will also be included. The purpose of this study is to examine the value of high intensity interval training and strength training to maximize aerobic training response in CR for women. This may contribute to establishing specific protocols and training guidelines for future program design for women in CR. Since a set of comprehensive CR guidelines pertaining to women is lacking, it is hoped that the results of this study will help us develop exercise protocols and regimen to better structure and modulate CR programs for optimal benefit to women.

Read the detailed description

Cardiovascular disease (CVD) is the foremost leading cause of death in women.1 More than 1 in 3 female adults are affected by CVD.2 Though the prevalence of CVD in women remains high, there is a relative paucity of research pertaining to women in Cardiac Rehabilitation (CR). Improvements in peak VO2 in CR are prognostically important 3-5 and several studies have shown that women increase their aerobic capacity in CR to a lesser degree than men.6,7 Even as women participate in many traditional CR programs, data specificity and subsequent research has yet to emerge in a meaningful way so that women-centered CR can be better customized and their outcomes properly assessed.

It is understood that women demonstrate a lower VO2 max than that of men8 on entry into CR which is often attributed to their smaller muscle mass, lower hemoglobin and blood volume, and smaller stroke volume relative to men.9 A finding of our previous study on aerobic capacity in patients entering cardiac rehabilitation revealed that values of peak VO2 on entry to CR were extremely low, particularly in women.6 It has been observed in the CR setting that women have lower physical function scores than men.10 Handgrip strength also differs between men and women.11 Baseline maximal exercise capacity of peak VO2 has been found to be the best predictors of baseline physical function score along with strength measures of leg press and bench press.10 Another study of ours revealed that while a peak VO2 below 15 was associated with high risk of annual all-cause mortality among men, a peak VO2 below 12 was associated with highest risk among women.12 Though women in another study had lower peak exercise capacities than men, they achieved similar relative improvements as a result of cardiac rehabilitation.13 Research in the field deserves further exploration as the results remain mixed. As women improve less than men in attaining peak VO2, we have put together a training program for women with a goal of optimizing their training potential in CR. This program combines the utilization of a training technique termed interval training along with specific strength training exercises of the legs. Previous studies that included both men and women with CAD have indicated that high intensity interval training might be more beneficial than moderate or standard intensity training in terms of improvements in aerobic fitness.14-16 However, the specificity of benefits for women remains rather elusive. Thus, studying variations in strength and power with appropriate interval training could help us attain better outcomes.

We hypothesize that women, irrespective of age, would be capable of high intensity interval training to improve peak aerobic capacity in the CR setting. Furthermore, since women often have a deficit of thigh strength entering CR, strength training will also be included. The purpose of this study is to examine the value of high intensity interval training and strength training to maximize aerobic fitness in Cardiac Rehabilitation for women. This may contribute to establishing specific protocols and training guidelines for future program design for women in CR. Since a set of comprehensive CR guidelines pertaining to women is lacking, it is hoped that the results of this study will help us develop exercise protocols and regimen to better structure and modulate CR programs for optimal benefit to women.

Study Design: Describe the research design, including a description of any new methodology and its advantage over existing methodologies.

This is a prospective study to be conducted at University of Vermont Cardiac Rehabilitation Center involving female cardiac patients. At entry to CR, data to be collected from patients participating in the study include: 1) Baseline characteristics such as age, body weight and height for calculation of BMI, systolic and diastolic blood pressure (rest), heart rate (rest, peak), medications, prior cardiac event etc., 2) Aerobic fitness assessment using a symptom-limited graded exercise tolerance test on treadmill to determine Peak metabolic equivalents (METs peak) and Peak VO2, 3) Strength measurement assessment using a single-repetition maximal lift (bench press for upper body and leg extension for lower body) and a handgrip dynamometer for handgrip strength, 4) Perceived exertion rate after each training session using BORG 6-20 scale18, 5) Self-reported physical functioning assessment using the Medical Outcomes Study Short Form-36 (MOS SF-36) survey questionnaire (0-100 scale) with 100 representing excellent physical functioning, 6) a co-morbidity score to determine the presence of peripheral vascular disease, cerebrovascular disease, chronic lung disease, or orthopedic limitations. If a co-morbid condition is present, it is quantified by severity as follows: 1, present but not exercising-limiting; 2, present and impacts on exercise performance; and 3, exercising-limiting; a total co-morbidity score ranging from 0 to 12 is to be determined for each participant, and 7) any "quality of life improvements" for participants as measured by the MacNew Heart Disease Health-Related Quality of Life Questionnaire.19 All of these measures with the exception of the MacNew questionnaire are collected on all CR entrants in the clinical setting.

The standard exercise training protocol will comprise of 3-one hour long sessions per week spanning 12 weeks, consisting of aerobic exercise and resistance training. Each session includes treadmill walking, rowing, cycling and aerobic exercise in the control group will be performed at an intensity of 70-85% of peak HR (moderate intensity) for a total of 45 minutes with rest periods as needed between equipment Patients will also participate in resistance training which will include 1 set of 10 repetitions at an intensity of 60-65% of the single repetition maximal lift (1-RM) of the following: leg extension, leg curl, bench press, shoulder press, lateral pull down, and bicep curl. For those who underwent CABG, upper body resistance training will take place 3 months post-operatively.

The high intensity interval training with more intensive strength training will consist of 3-one hour sessions over the course of 12 weeks. For this group, all aerobic training will comprise of "high intensity interval treadmill walking" (HIT). Patients will warm up for 5 minutes at 60-70% of peak HR followed by 4 minute intervals to achieve 90-95% of peak HR. In between each interval will be a 4 minute walking period at 50-60% of peak HR. You will also perform other types of exercise such as cycling and rowing for up to a total of 45 minutes of aerobic exercise. You can rest, as needed, in between different types of exercise equipment. Additionally, this group will undergo strength training as described above, however, they will do 2 sets of 10 repetitions for upper leg exercises at an intensity of 80% 1-RM.

At entry to CR, the study participants will be asked to fill out the following questionnaires:

  1. Medical Outcomes Study Short Form-36 (MOS SF-36) survey questionnaire to report the physical functioning
  2. MacNew Heart Disease Health-Related Quality of Life Questionnaire to measure quality of life improvement

At the completion of the study after 12 weeks, the participants will be asked to do the same measures. Random IDs will be given to patients filling out the survey instruments to maintain privacy and confidentiality. Additionally, the results will be stored on a password-protected secure computer network of UVMMC.

Statistical Considerations:

Power calculations undertaken by us (80% power with 5% level of significance) based on Wisloff study15 suggested that a sample size of 19 per group is needed to detect a difference of 30% between groups in Peak VO2 by exercise training regimen. We intend to conduct an interim updated power analysis once we have 10 patients to better fine tune the power analysis.

Baseline characteristics will be presented as mean SD. Non- paired t-tests will be used for comparison between groups at baseline (pre-test), at the conclusion of the study (post-test), and percent changes after exercise regimen. ANOVA for repeated measures will be used for analyzing the effect of the exercise regimen between groups. A level of significance of P<0.05 will be used to indicate statistical significance.

All eligible participants in the study will perform the CR exercise training under the supervision of exercised physiologists. This study presents minimal risk to participants as indeed, CR participation yields a 25% decrease in overall mortality and a 31% decrease in hospitalizations in year 1.20

Benefits of CR include improved overall cardiovascular health, knowledge of physical functioning opportunities and limitations, and ability to both undertake and continue exercise for a longer span of time beyond the end of the study. An underlying assumption of the study is optimization of exercise might yield a greater training increase in Peak VO2 in the HIT group along with possible greater improvements in fitness and quality of life.

Both groups will obtain all of the standard benefits of CR which include a lower mortality rate, a lower re-hospitalization rate, and an improved quality of life.

Data Safety and Monitoring:

Hard copy of paper data will be stored in locked office and file cabinets. All electronic data will be password protected and stored on the UVMMC secured network server.

Being tested
Exercise training
Medical subject headings
Coronary Artery Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT03438968
Study groupRoleWhat they receive
High-Intensity aerobic trainingExperimentalIndividuals will exercise using a high-intensity interval exercise training protocol
Receives: Behavioral: Exercise training
Standard Moderate continuous trainingActive comparatorIndividuals will exercise using a standard moderate intensity continuous exercise training protocol
Receives: Behavioral: Exercise training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Aerobic Fitness

    Peak VO2 measured with cardiopulmonary exercise testing

    Measured: 4-month study participation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Feb 2018
  2. Study start24 Aug 2017
  3. Primary completion31 Dec 2018 (estimated)
  4. Study completion30 Apr 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized controlled trial
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03438968
Sponsor's protocol ID
18-0008
Status last verified
Feb 2018
First submitted
13 Feb 2018
Last updated
20 Feb 2018
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Khadanga S, Savage PD, Pecha A, Rengo J, Ades PA. Optimizing Training Response for Women in Cardiac Rehabilitation: A Randomized Clinical Trial. JAMA Cardiol. 2022 Feb 1;7(2):215-218. doi: 10.1001/jamacardio.2021.4822.

    PubMed 34817540

Questions about this trial

What is this clinical trial studying?

A study testing Exercise training in people with Exercise Training and Coronary Artery Disease, run by University of Vermont at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Philip A Ades, MD (802 847 4514, philip.ades@uvmhealth.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Aerobic Fitness (time frame: 4-month study participation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03438968, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in